340 likes | 528 Views
ACTION Registry-GWTG Results: January 1, 2009 – December 31, 2009. Current Site Distribution. Active Sites = 539. WA (8). ME (1). VT (0). ND (1). MT (2). MI. NH (1). MN (6). NY (18). OR (10). MA (6). WI (7). SD (1). RI (1). ID (2). MI (11). WY (0). CT (6). PA (27).
E N D
ACTION Registry-GWTG Results:January 1, 2009 – December 31, 2009
Current Site Distribution Active Sites = 539 WA (8) ME (1) VT (0) ND (1) MT (2) MI NH (1) MN (6) NY (18) OR (10) MA (6) WI (7) SD (1) RI (1) ID (2) MI (11) WY (0) CT (6) PA (27) IA (6) NJ (6) NE (6) OH (30) DE (0) NV (7) IL (33) IN (17) WV (1) MD (12) VA (13) UT (2) CO (13) KY (4) MO (18) KS (9) DC (0) CA (36) NC (25) TN (19) SC (12) OK (7) AR (1) AZ (5) NM (2) AL (9) GA (14) MS (6) LA (7) TX (64) FL (36) AK (1) PR(2) HI (4) Last updated: 4/13/2010
Baseline Characteristics - STEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
Hospital Presentation Characteristics - STEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
In-Hospital Outcomes - STEMI *Unadjusted mortality ** Among non-CABG pts ACTION Registry-GWTG DATA: January 1.2009 – December 31, 2009
Use of Reperfusion Therapy for STEMI STEMI N = 23,190 Reperfusion N = 18,871 (81%) Not Eligible for Reperfusion Therapy Contraindication Listed N= 2,898 (13%) No Reperfusion – No Contraindication Listed N = 1333 (6%) Primary PCI – 88%* Fibrinolytics – 11%* Both PCI + Lytics – 1%* 94% of eligible patients reperfused ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009 * Among patients receiving reperfusion
STEMI – Door to Balloon and Door to Needle Times:Cumulative 12 Month Data ACTION Registry-GWTG DATA: January 1,2009 – December 31, 2009 DTB = 1st Door to Balloon for Primary PCI DTN = Door to Needle for Lytics
STEMI Primary PCI Results -Non-Transfer Patients with DTB 90 mins 73% of the primary PCI patients are not transferred in
STEMI Primary PCI Results - DTB Benchmarks for Transfer-In Patients 1st Door to Balloon < 90 Minutes 1st Door to Balloon < 120 Minutes 27% of the primary PCI patients are transferred in
STEMI Door-to-Balloon Times –Median Times for Transfer In and Non-Transfer In Patients 250 240 230 220 210 200 190 180 170 160 159 150 147 Time (min) 143 140 142 130 123 117 120 113 112 110 100 96 91 96 90 79 92 77 77 80 76 63 70 61 62 60 62 49 50 48 48 40 48 30 20 10 0 Q1 09 Q2 09 Q3 09 Q4 09 Transfer in DTB Times Non-Transfer in DTB Times
STEMI Acute (< 24 hrs) Medications * Heparin and GP IIb-IIIa administered any time during hospitalization ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009 n
STEMI Revascularization Strategy Trends MedicallyManaged PCI CABG ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
STEMI Discharge Medications % Use ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
STEMI Discharge Interventions ACTION Registry-GWTG DATA: January 1,2009 – December 31, 2009
Baseline Characteristics - NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
Hospital Presentation Characteristics -NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
In-Hospital Outcomes - NSTEMI *Unadjusted mortality ** Among non-CABG pts ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
NSTEMI Acute (< 24 hrs) Medications * Heparin and GP IIb-IIIa administered any time during hospitalization ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
NSTEMI Time from Presentation to Procedure ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
NSTEMI Acute Medication Overdosing Trends * Infusion (> 15 units/kg/hr) or bolus (> 70 units/kg) # Initial dose (> 1.05 mg/kg) or total 24 hr dose (> 10 mg over recommended) ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
NSTEMI Invasive Cardiac Procedures ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
NSTEMI Revascularization Strategy Trends Medically Managed PCI CABG ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
NSTEMI Discharge Medications ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
NSTEMI Discharge Clopidogrel Use byRevascularization Strategies ACTION Registry-GWTG DATA: January 1, 2009– December 31, 2009
NSTEMI Discharge Interventions ACTION Registry-GWTG DATA: January 1, 2009– December 31, 2009
Baseline Characteristics –STEMI vs. NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
Age Distribution –STEMI vs. NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
Location of First Evaluation –STEMI vs. NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
Hospital Presentation Characteristics - STEMI vs. NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
In-Hospital Outcomes - STEMI vs. NSTEMI *Unadjusted mortality ** Among non-CABG pts ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
Non-CABG Major Bleeding and Transfusion –STEMI vs. NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
Acute Medications - STEMI vs NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
Discharge Medications - STEMI vs NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009
Discharge Interventions – STEMI vs. NSTEMI ACTION Registry-GWTG DATA: January 1, 2009 – December 31, 2009